MedinCell S.A. (EPA: MEDCL)

MedinCell Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 20, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	499	276	246	186	288	120
Market Cap Growth	11.97%	11.97%	32.11%	-35.19%	140.10%	-4.59%
Enterprise Value	544	315	281	195	304	137
Last Close Price	17.16	9.59	9.81	7.42	11.70	5.96
Forward PE	-	-	-	6.91	-	-
PS Ratio	40.83	23.08	18.03	22.35	35.13	19.96
PB Ratio	-6.75	-6.75	-5.82	-13.94	31.51	-7.51
P/TBV Ratio	-	-	-	-	37.64	-
EV/Sales Ratio	45.57	26.37	20.55	23.37	37.15	22.78
Debt / Equity Ratio	-1.58	-1.58	-1.36	-3.55	4.75	-2.12
Asset Turnover	0.36	0.36	0.37	0.15	0.18	0.18
Quick Ratio	1.59	1.59	0.33	0.84	4.01	2.54
Current Ratio	1.66	1.66	0.34	0.89	4.14	2.69
Return on Assets (ROA)	-39.49%	-39.49%	-40.78%	-27.58%	-26.02%	-36.71%
Return on Capital (ROIC)	-66.61%	-66.61%	-60.63%	-34.37%	-33.63%	-46.85%
Earnings Yield	-5.13%	-9.08%	-13.00%	-13.31%	-6.60%	-19.97%
FCF Yield	-2.45%	-4.44%	-8.76%	-12.33%	-4.44%	-10.95%
Buyback Yield / Dilution	-12.83%	-12.83%	-1.39%	-12.79%	-9.52%	-16.53%
Total Shareholder Return	-12.83%	-12.83%	-1.39%	-12.79%	-9.52%	-16.53%

Source: S&P Capital IQ. Standard template. Financial Sources.